Publications 2020

Berger I, Berland S, Rodriguez JR, Aamodt H, Sitek JC, Jørgensen K, Johansen TEB (2020)
Birt-Hogg-Dubé-syndrom
Tidsskr Nor Laegeforen, 140 (6)
DOI 10.4045/tidsskr.18.0848, PubMed 32321218

Berger I, Aamodt H, Jorgensen K, Berland S, Sitek JC, Johansen TEB, Rodriguez JR (2020)
Birt-Hogg-Dube-syndrome
Tidsskr. Nor. Laegeforen., 140 (6), 565-569

Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB (2020)
Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
Int J Antimicrob Agents, 56 (1), 105935
DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620

Publications 2019

Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME (2019)
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol, 38 (1), 17-26
DOI 10.1007/s00345-019-02837-0, PubMed 31183524

Tandogdu Z, Koves B, Cai T, Cek M, Tenke P, Naber K, Wagenlehner F, Johansen TEB (2019)
Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
World J Urol, 38 (1), 27-34
DOI 10.1007/s00345-019-02963-9, PubMed 31555835

Publications 2018

Kløw NE, Grøtta OJ, Bay D, Sandbæk G, Johansen TEB, Hagen T, Baco E (2018)
Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
Acta Radiol, 60 (9), 1175-1180
DOI 10.1177/0284185118813709, PubMed 30450921

Publications 2017

Cai T, Koves B, Johansen TE (2017)
Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
Curr Opin Urol, 27 (2), 107-111
DOI 10.1097/MOU.0000000000000368, PubMed 27906777

McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V (2017)
A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
Rev Urol, 19 (4), 213-220
DOI 10.3909/riu0780, PubMed 29472825

Publications 2016

Bartoletti R, Cai T, Wagenlehner FM, Naber K, Johansen TEB (2016)
Treatment of Urinary Tract Infections and Antibiotic Stewardship
Eur. Urol. Suppl., 15 (4), 81-87

Cai T, Bonkat G, Tandogdu Z, Bartoletti R, Wagenlehner FME, Grabe M, Johansen TEB (2016)
How to Use Antimicrobial Prophylaxis in Urological Procedures
Eur Urol Focus, 2 (4), 348-350
DOI 10.1016/j.euf.2016.02.010, PubMed 28723464

Cai T, Verze P, Palmieri A, Gacci M, Lanzafame P, Malossini G, Nesi G, Bonkat G, Wagenlehner FM, Mirone V, Bartoletti R, Johansen TE (2016)
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
Urology, 99, 100-105
DOI 10.1016/j.urology.2016.10.016, PubMed 27773650

Johansen TEB, Naber KG (2016)
Working on a Dream
Eur. Urol. Suppl., 15 (4), 69-70

Kulchavenya E, Naber K, Johansen TEB (2016)
Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
Eur. Urol. Suppl., 15 (4), 112-121

Smelov V, Naber K, Johansen TEB (2016)
Improved Classification of Urinary Tract Infection: Future Considerations
Eur. Urol. Suppl., 15 (4), 71-80

Tandogdu Z, Johansen TEB, Bartoletti R, Wagenlehner F (2016)
Management of the Urologic Sepsis Syndrome
Eur. Urol. Suppl., 15 (4), 102-111

Vahlensieck W, Perepanova T, Johansen TEB, Tenke P, Naber KG, Wagenlehner FME (2016)
Management of Uncomplicated Recurrent Urinary Tract Infections
Eur. Urol. Suppl., 15 (4), 95-101

Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Köves B, Naber K, Perepanova T, Tenke P, Wullt B, Bogenhard F, Johansen TE (2016)
The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections
Pathogens, 5 (1)
DOI 10.3390/pathogens5010010, PubMed 26797640

Publications 2015

Johansen TE (2015)
[Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (10), 924-5
DOI 10.4045/tidsskr.15.0317, PubMed 26037750

Johansen TE (2015)
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1535-6
DOI 10.4045/tidsskr.15.0928, PubMed 26394579

Johansen TE (2015)
[Re: The problematical prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1536
DOI 10.4045/tidsskr.15.0915, PubMed 26394580

Tandoğdu Z, Bartoletti R, Cai T, Çek M, Grabe M, Kulchavenya E, Köves B, Menon V, Naber K, Perepanova T, Tenke P, Wullt B, Johansen TE, Wagenlehner F (2015)
Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013
World J Urol, 34 (8), 1193-200
DOI 10.1007/s00345-015-1722-1, PubMed 26658886

Publications 2014

Johansen TE (2014)
Reliable diagnostic work-up of rare urinary infections
Tidsskr Nor Laegeforen, 134 (5), 533
DOI 10.4045/tidsskr.13.1198, PubMed 24621913

Johansen TE, Naber KG (2014)
Urinary Tract Infections
Antibiotics (Basel), 3 (3), 375-7
DOI 10.3390/antibiotics3030375, PubMed 27025751

Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Tenke P, Köves B, Johansen TE (2014)
An update on prevention and treatment of catheter-associated urinary tract infections
Curr Opin Infect Dis, 27 (1), 102-7
DOI 10.1097/QCO.0000000000000031, PubMed 24345923

Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014)
Reducing infection rates after prostate biopsy
Nat Rev Urol, 11 (2), 80-6
DOI 10.1038/nrurol.2013.322, PubMed 24418806

Publications 2011

Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, Naber KG (2011)
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
Int J Antimicrob Agents, 38 Suppl, 64-70
DOI 10.1016/j.ijantimicag.2011.09.009, PubMed 22018988

Matsumoto T, Wagenlehner FM, Johansen TE (2011)
Antimicrobial therapy of urinary tract infections
Int J Antimicrob Agents, 38 Suppl, 1-2
DOI 10.1016/j.ijantimicag.2011.09.001, PubMed 22018987

Montvilas P, Solvig J, Johansen TE (2011)
Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates
Eur J Radiol, 80 (2), 553-8
DOI 10.1016/j.ejrad.2011.01.109, PubMed 21353753

Publications 2010

Mouraviev V, Johansen TE, Polascik TJ (2010)
Contemporary results of focal therapy for prostate cancer using cryoablation
J Endourol, 24 (5), 827-34
DOI 10.1089/end.2009.0546, PubMed 20443724

Publications 2008

Johansen TE (2008)
[PSA based screening for prostatic cancer]
Tidsskr Nor Laegeforen, 128 (22), 2612-4
PubMed 19023357

Johansen TE, Berg C (2008)
[Hormone treatment of prostate cancer in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2558-62
PubMed 19023350

Publications 2007

Johansen TE, Istad JA (2007)
Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
Scand J Urol Nephrol, 41 (2), 124-31
DOI 10.1080/00365590600911266, PubMed 17454951

Publications 2006

Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P, PEP and PEAP-study investigators, Board of the European Society of Infections in Urology (2006)
Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies
Int J Antimicrob Agents, 28 Suppl 1, S91-107
DOI 10.1016/j.ijantimicag.2006.05.005, PubMed 16829052

Publications 2005

Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, Grabe M, Lobel B, Redorta JP, Tenke P, Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office (2005)
EAU guidelines for the management of genitourinary tuberculosis
Eur Urol, 48 (3), 353-62
DOI 10.1016/j.eururo.2005.03.008, PubMed 15982799

Johansen TE (2005)
[Radical therapy for prostate cancer in Norway]
Tidsskr Nor Laegeforen, 125 (12), 1658-60
PubMed 15976834

Johansen TE (2005)
[Cryotherapy for prostate cancer]
Tidsskr Nor Laegeforen, 125 (12), 1661-3
PubMed 15976835

Publications 2004

Johansen TE (2004)
Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urology
Int J Antimicrob Agents, 23 Suppl 1, S30-4
DOI 10.1016/j.ijantimicag.2003.09.003, PubMed 15037326

Johansen TE (2004)
The role of imaging in urinary tract infections
World J Urol, 22 (5), 392-8
DOI 10.1007/s00345-004-0414-z, PubMed 15290204

Publications 2003

Johansen TE (2003)
[Drugs against urinary incontinence]
Tidsskr Nor Laegeforen, 123 (2), 178-9
PubMed 12607502

Johansen TE (2003)
[A public disease without guidelines]
Tidsskr Nor Laegeforen, 123 (17), 2410
PubMed 14508529

Publications 2002

Johansen TE (2002)
[Ritual circumcision]
Tidsskr Nor Laegeforen, 122 (1), 15
PubMed 11851285

Johansen TE (2002)
[Renal cancer in a 20-year perspective]
Tidsskr Nor Laegeforen, 122 (25), 2430
PubMed 12448108

Johansen TE (2002)
[Drugs against symptomatic, benign prostatic hyperplasia]
Tidsskr Nor Laegeforen, 122 (26), 2544-5
PubMed 12522881